Longeveron continued to climb over 50% in premarket trading as FDA approved its Lomecel-B for rare pediatric disease designation<blockquote>随着FDA批准其Lomecel-B用于罕见儿科疾病指定,Longeveron在盘前交易中继续攀升超过50%</blockquote>
Dow kicks off Wednesday trade down nearly 300 points after better-than-expected ADP report, rising yields<blockquote>ADP报告好于预期、收益率上升后,道指周三开盘下跌近300点</blockquote>